Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02414139
Title Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications

lung non-small cell carcinoma

Therapies

Capmatinib

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | BEL | AUT

Facility Status City State Zip Country Details
Pacific Shores Medical Group SC Long Beach California 90813 United States Details
University of California at Los Angeles Dept of Onc Los Angeles California 90095 United States Details
University of California Irvine Medical Center Chao Family Chao Family Comp Cancer Center Orange California 92868 United States Details
H Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
University of Iowa Hospitals & Clinics SC-3 Iowa City Iowa 52242 United States Details
Massachusetts General Hospital MGH Cancer Center Boston Massachusetts 02114 United States Details
VA Ann Arbor Health System VA Ann Arbor Health System Ann Arbor Michigan 48105 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Oregon Health and Science University SC Portland Oregon 97239 United States Details
Lehigh Valley Health Network SC Allentown Pennsylvania 18103 United States Details
Andrew and Patel Associates Camp Hill Pennsylvania 17011 United States Details
Cancer Therapy and Research Center UT Health Science Center SC-5 San Antonio Texas 78229 United States Details
University of Utah / Huntsman Cancer Institute Oncology Salt Lake City Utah 84103 United States Details
Novartis Investigative Site Caba Buenos Aires C1426ANZ Argentina Details
Novartis Investigative Site Buenos Aires Caba C1431FWO Argentina Details
Novartis Investigative Site La Rioja 5300 Argentina Details
Novartis Investigative Site Wien 1210 Austria Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Marseille cedex 20 Bouches Du Rhone 13915 France Details
Novartis Investigative Site Dijon Cedex Cote D Or 21034 France Details
Novartis Investigative Site Clermont-Ferrand 63011 France Details
Novartis Investigative Site La Tronche 38700 France Details
Novartis Investigative Site Lille 59000 France Details
Novartis Investigative Site Marseille 13273 France Details
Novartis Investigative Site Paris 75970 France Details
Novartis Investigative Site Pierre Benite Cedex 69495 France Details
Novartis Investigative Site Rennes 35043 France Details
Novartis Investigative Site Strasbourg Cedex 67091 France Details
Novartis Investigative Site Heidelberg Baden-Württemberg 69126 Germany Details
Novartis Investigative Site Koeln Nordrhein-Westfalen 50937 Germany Details
Novartis Investigative Site Berlin 13125 Germany Details
Novartis Investigative Site Frankfurt 60590 Germany Details
Novartis Investigative Site Gottingen 37075 Germany Details
Novartis Investigative Site Halle (Saale) 06120 Germany Details
Novartis Investigative Site Hamburg 20251 Germany Details
Novartis Investigative Site Hannover 30625 Germany Details
Novartis Investigative Site Homburg 66421 Germany Details
Novartis Investigative Site Muenchen 81925 Germany Details
Novartis Investigative Site Nuernberg 90419 Germany Details
Novartis Investigative Site Ravensburg 88214 Germany Details
Novartis Investigative Site Tübingen 72076 Germany Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Ramat Gan 52621 Israel Details
Novartis Investigative Site Tel Aviv 6423906 Israel Details
Novartis Investigative Site Bologna BO 40138 Italy Details
Novartis Investigative Site Brescia BS 25123 Italy Details
Novartis Investigative Site Catania CT 95124 Italy Details
Novartis Investigative Site Catanzaro CZ 88100 Italy Details
Novartis Investigative Site Meldola FC 47014 Italy Details
Novartis Investigative Site Firenze FI 50134 Italy Details
Novartis Investigative Site Monza MB 20900 Italy Details
Novartis Investigative Site Milano MI 20141 Italy Details
Novartis Investigative Site Milano MI 20162 Italy Details
Novartis Investigative Site Modena MO 41124 Italy Details
Novartis Investigative Site Roma RM 00155 Italy Details
Novartis Investigative Site Verona VR 37126 Italy Details
Novartis Investigative Site Napoli 80131 Italy Details
Aichi Cancer Center Hospital Nagoya City Aichi 464-8681 Japan Details
Nagoya University Hospital Nagoya Aichi 466-8560 Japan Details
National Cancer Center Hospital East Kashiwa-City Chiba 277-8577 Japan Details
National Kyushu Cancer Center Minami-Ku Fukuoka 811-1395 Japan Details
Hyogo Cancer Center Akashi-city Hyogo 673-8558 Japan Details
Sendai Kousei Hospital Sendai-city Miyagi 980-0873 Japan Details
Okayama University Hospital Okayama-city Okayama 700-8558 Japan Details
Kinki University Hospital OsakaSayama-city Osaka 589-8511 Japan Details
National Cancer Center Hospital Chuo-ku Tokyo 104-0045 Japan Details
Novartis Investigative Site Koto ku Tokyo 135 8550 Japan Details
National Hospital Organization, Yamaguchi-Ube Medical Center Ube-city Yamaguchi 755-0241 Japan Details
Novartis Investigative Site Bundang Gu Gyeonggi Do 13620 Korea, Republic of Details
Novartis Investigative Site Gyeonggi do Korea 10408 Korea, Republic of Details
Novartis Investigative Site Seoul 03080 Korea, Republic of Details
Novartis Investigative Site Ashrafieh 166830 Lebanon Details
Novartis Investigative Site Mexico Distrito Federal 14080 Mexico Details
NKI-AVL, Department of Thoracic-Oncology Amsterdam 1066 CX Netherlands Details
Novartis Investigative Site Groningen 9713 GZ Netherlands Details
Novartis Investigative Site Maastricht 6229 HX Netherlands Details
Novartis Investigative Site Rotterdam 3015 GD Netherlands Details
Novartis Investigative Site Oslo NO 0424 Norway Details
Novartis Investigative Site Moscow 109028 Russian Federation Details
Novartis Investigative Site Saint Petersburg 192148 Russian Federation Details
Novartis Investigative Site Tambov 392000 Russian Federation Details
Novartis Investigative Site Singapore 119228 Singapore Details
Novartis Investigative Site Singapore 169610 Singapore Details
Novartis Investigative Site Sevilla Andalucia 41017 Spain Details
Novartis Investigative Site Oviedo Asturias 33011 Spain Details
Novartis Investigative Site Barcelona Catalunya 08035 Spain Details
Novartis Investigative Site Barcelona Catalunya 08036 Spain Details
Novartis Investigative Site La Coruna Galicia 15006 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
Novartis Investigative Site Stockholm SE-171 76 Sweden Details
Novartis Investigative Site Kaohsiung 82445 Taiwan Details
Novartis Investigative Site Taipei 10002 Taiwan Details
Novartis Investigative Site Taoyuan 33305 Taiwan Details
Novartis Investigative Site Birmingham B9 5SS United Kingdom Details
Novartis Investigative Site London W6 8RF United Kingdom Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field